Skip to content

Nasdaq · CIK 0000818033

HRTX HERON THERAPEUTICS, INC. /DE/

Insider trading from SEC Form 4. Last filing Feb 3, 2026. Close $0.41 on Oct 9, 2026, +52% from the 52-week low and -72% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company

Price and insider trades, last year

HRTXOct 9, 2026 · close 0.41

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at HERON THERAPEUTICS, INC. /DE/, scored.

ScoreInsiderValueHoldingsPrice contextFiled
43ModerateRubric Capital Management LP
owner
buy
$3.6M
2,387,225 shares
+9%-
54ModerateAdam Morgan
director
buy
$2.6M
1,766,546 shares
+25%-

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jan 31, 2026Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+34,789--571,710Feb 3, 2026
Jan 31, 2026William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+11,695--181,773Feb 3, 2026
Jan 30, 2026Craig A Johnson
director
AGrant or award
Common Stock
+53,960$0.00$053,960Feb 3, 2026
Jan 30, 2026Sharmila Dissanaike
director
AGrant or award
Common Stock
+53,960$0.00$053,960Feb 3, 2026
Jan 30, 2026Ira Duarte
EVP, Chief Financial Officer
AGrant or award
Restricted Stock Unitsderivative
+216,562$0.00$0216,562Feb 3, 2026
Jan 30, 2026Mark Earl Hensley
Chief Operating Officer
AGrant or award
Restricted Stock Unitsderivative
+188,315$0.00$0188,315Feb 3, 2026
Jan 30, 2026Michael Kaseta
director
AGrant or award
Common Stock
+53,960$0.00$053,960Feb 3, 2026
Jan 30, 2026Adam Morgan
director
AGrant or award
Common Stock
+53,960$0.00$0123,737Feb 3, 2026
Jan 30, 2026Thomas Cusack
director
AGrant or award
Common Stock
+53,960$0.00$053,960Feb 3, 2026
Jan 30, 2026Waage Christian
director
AGrant or award
Common Stock
+53,960$0.00$053,960Feb 3, 2026
Jan 30, 2026William P Forbes
EVP, Chief Development Officer
AGrant or award
Restricted Stock Unitsderivative
+188,315$0.00$0188,315Feb 3, 2026
Jan 30, 2026Craig A Collard
Chief Executive Officer
AGrant or award
Restricted Stock Unitsderivative
+800,337$0.00$0800,337Feb 3, 2026
Jan 31, 2026Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+11,695--195,356Feb 3, 2026
Jan 31, 2026Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-11,695$0.00$0140,332Feb 3, 2026
Jan 30, 2026Craig A Collard
Chief Executive Officer
AGrant or award
Performance Stock Unitsderivative
+800,336$0.00$0800,336Feb 3, 2026
Jan 30, 2026Mark Earl Hensley
Chief Operating Officer
AGrant or award
Performance Stock Unitsderivative
+188,314$0.00$0188,314Feb 3, 2026
Jan 31, 2026Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-34,789$0.00$0417,464Feb 3, 2026
Jan 31, 2026William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-11,695$0.00$0140,332Feb 3, 2026
Jan 30, 2026Ira Duarte
EVP, Chief Financial Officer
AGrant or award
Performance Stock Unitsderivative
+216,561$0.00$0216,561Feb 3, 2026
Jan 30, 2026William P Forbes
EVP, Chief Development Officer
AGrant or award
Performance Stock Unitsderivative
+188,314$0.00$0188,314Feb 3, 2026
Jan 19, 2026Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+3,875--183,661Jan 20, 2026
Jan 19, 2026Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+13,797--536,921Jan 20, 2026
Jan 19, 2026William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+3,875--170,078Jan 20, 2026
Jan 19, 2026Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-13,797$0.00$0110,375Jan 20, 2026
Jan 19, 2026Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-3,875$0.00$030,994Jan 20, 2026
Jan 19, 2026William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-3,875$0.00$030,994Jan 20, 2026
Nov 8, 2025Thomas Cusack
director
AGrant or award
Common Stock
+37,879--37,879Nov 12, 2025
Nov 8, 2025Thomas Cusack
director
AGrant or award
Stock Option (Right to Buy)derivative
+227,272$1.10$250k227,272Nov 12, 2025
Oct 31, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+11,694--166,203Nov 4, 2025
Oct 31, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+34,789--523,124Nov 4, 2025
Oct 31, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+11,694--179,786Nov 4, 2025
Oct 31, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-11,694$0.00$0152,027Nov 4, 2025
Oct 31, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-11,694$0.00$0152,027Nov 4, 2025
Oct 31, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-34,789$0.00$0452,253Nov 4, 2025
Oct 19, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+13,797--488,335Oct 21, 2025
Oct 19, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+3,874--168,092Oct 21, 2025
Oct 19, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+3,874--154,509Oct 21, 2025
Oct 19, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-13,797$0.00$0124,172Oct 21, 2025
Oct 19, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-3,874$0.00$034,869Oct 21, 2025
Oct 19, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-3,874$0.00$034,869Oct 21, 2025
Oct 15, 2025Rubric Capital Management LP
owner
CConversion
Common Stock, par value $0.01 per share ("Common Stock")indirect: See footnotes
+946,100--30,046,828Oct 17, 2025
Oct 15, 2025Rubric Capital Management LP
owner
CConversion
Series A Convertible Preferred Stock ("Preferred Shares")derivativeindirect: See footnotes
-94,610$0.00$00Oct 17, 2025
Aug 8, 2025Rubric Capital Management LP
owner
POpen-market purchase
Common Stock, par value $0.01 per share ("Common Stock")indirect: See footnotes
+2,387,225$1.50$3.6M29,100,728Aug 12, 2025
Aug 8, 2025Adam Morgan
director
POpen-market purchase
Common Stockindirect: By Velan Capital Master Fund LP
+1,766,546$1.50$2.6M8,753,290Aug 12, 2025
Aug 8, 2025Rubric Capital Management LP
owner
POpen-market purchase
Convertible Senior Unsecured Promissory Notes ("Notes")derivativeindirect: See footnotes
-$33,250,000.00--Aug 12, 2025
Aug 8, 2025Rubric Capital Management LP
owner
POpen-market purchase
Series A Convertible Preferred Stock ("Preferred Shares")derivativeindirect: See footnotes
+94,610$15.00$1.4M94,610Aug 12, 2025
Aug 8, 2025Adam Morgan
director
POpen-market purchase
Series A Convertible Preferred Stockderivativeindirect: By Velan Capital Master Fund LP
+70,012$15.00$1.1M70,012Aug 12, 2025
Jul 31, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+34,789--474,538Aug 4, 2025
Jul 31, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+11,695--164,218Aug 4, 2025
Jul 31, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+11,695--150,635Aug 4, 2025
Jul 31, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-34,789$0.00$0487,042Aug 4, 2025
Jul 31, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-11,695$0.00$0163,721Aug 4, 2025
Jul 31, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-11,695$0.00$0163,721Aug 4, 2025
Jul 19, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+13,797--439,749Jul 22, 2025
Jul 19, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+3,874--152,523Jul 22, 2025
Jul 19, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+3,874--138,940Jul 22, 2025
Jul 19, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-13,797$0.00$0137,969Jul 22, 2025
Jul 19, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-3,874$0.00$038,743Jul 22, 2025
Jul 19, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-3,874$0.00$038,743Jul 22, 2025
Jun 16, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+12,500--148,649Jun 17, 2025
Jun 16, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
+12,500$0.00$025,000Jun 17, 2025
Jun 6, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+12,500--135,066Jun 9, 2025
Jun 6, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-12,500$0.00$025,000Jun 9, 2025
May 6, 2025Mark Earl Hensley
Chief Operating Officer
AGrant or award
Restricted Stock Unitsderivative
+500,000$0.00$0500,000May 7, 2025
Apr 30, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+34,789--425,952May 2, 2025
Apr 30, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+11,694--136,149May 2, 2025
Apr 30, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+11,694--122,566May 2, 2025
Apr 30, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-34,789$0.00$0521,831May 2, 2025
Apr 30, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
+11,694$0.00$0175,416May 2, 2025
Apr 30, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-11,694$0.00$0175,416May 2, 2025
Apr 19, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+13,796--391,163Apr 22, 2025
Apr 19, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+3,875--124,455Apr 22, 2025
Apr 19, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+3,875--110,872Apr 22, 2025
Apr 19, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-13,796$0.00$0151,766Apr 22, 2025
Apr 19, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
+3,875$0.00$042,617Apr 22, 2025
Apr 19, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Restricted Stock Unitsderivative
-3,875$0.00$042,617Apr 22, 2025
Apr 3, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+62,500--377,367Apr 3, 2025
Apr 3, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-62,500$0.00$0125,000Apr 3, 2025
Jan 31, 2025Craig A Collard
Chief Executive Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+1,113,240$0.00$01,113,240Feb 4, 2025
Jan 31, 2025Ira Duarte
EVP, Chief Financial Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+374,220$0.00$0374,220Feb 4, 2025
Jan 31, 2025William P Forbes
EVP, Chief Development Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+374,220$0.00$0374,220Feb 4, 2025
Jan 31, 2025Craig A Collard
Chief Executive Officer
AGrant or award
Restricted Stock Unitsderivative
+556,620$0.00$0556,620Feb 4, 2025
Jan 31, 2025Ira Duarte
EVP, Chief Financial Officer
AGrant or award
Restricted Stock Unitsderivative
+187,110$0.00$0187,110Feb 4, 2025
Jan 31, 2025William P Forbes
EVP, Chief Development Officer
AGrant or award
Restricted Stock Unitsderivative
+187,110$0.00$0187,110Feb 4, 2025
Jan 30, 2025Waage Christian
director
AGrant or award
Common Stock
+17,950$0.00$084,130Feb 3, 2025
Jan 30, 2025Sharmila Dissanaike
director
AGrant or award
Common Stock
+17,950$0.00$087,180Feb 3, 2025
Jan 30, 2025Adam Morgan
director
AGrant or award
Common Stock
+17,950$0.00$069,777Feb 3, 2025
Jan 30, 2025Susan Rodriguez
director
AGrant or award
Common Stock
+17,950$0.00$087,180Feb 3, 2025
Jan 30, 2025Craig A Johnson
director
AGrant or award
Common Stock
+17,950$0.00$083,770Feb 3, 2025
Jan 30, 2025Michael Kaseta
director
AGrant or award
Common Stock
+17,950$0.00$055,829Feb 3, 2025
Jan 30, 2025Waage Christian
director
AGrant or award
Stock Option (Right to Buy)derivative
+35,900$1.73$62k35,900Feb 3, 2025
Jan 30, 2025Sharmila Dissanaike
director
AGrant or award
Stock Option (Right to Buy)derivative
+35,900$1.73$62k35,900Feb 3, 2025
Jan 30, 2025Susan Rodriguez
director
AGrant or award
Stock Option (Right to Buy)derivative
+35,900$1.73$62k35,900Feb 3, 2025
Jan 30, 2025Craig A Johnson
director
AGrant or award
Stock Option (Right to Buy)derivative
+35,900$1.73$62k35,900Feb 3, 2025
Jan 30, 2025Michael Kaseta
director
AGrant or award
Stock Option (Right to Buy)derivative
+35,900$1.73$62k35,900Feb 3, 2025
Jan 30, 2025Adam Morgan
director
AGrant or award
Stock Option (Right to Buy)derivative
+35,900$1.73$62k35,900Feb 3, 2025
Jan 19, 2025William P Forbes
EVP, Chief Development Officer
MOption exercise
Common Stock
+3,874--106,997Jan 22, 2025
Jan 19, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Common Stock
+13,797--314,867Jan 22, 2025
Jan 19, 2025Ira Duarte
EVP, Chief Financial Officer
MOption exercise
Common Stock
+3,874--120,580Jan 22, 2025
Jan 19, 2025Craig A Collard
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-13,797$0.00$0165,562Jan 22, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

HRTX insider trading: HERON THERAPEUTICS, INC. /DE/ | InsiderTell